Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer’s disease pathology in a mouse model
- 1 February 2022
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 209, 102212
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s diseaseBMC Neurology, 2013
- Plasma Signaling Proteins in Persons at Genetic Risk for Alzheimer DiseaseArchives of Neurology, 2012
- ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse ModelsScience, 2012
- Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's diseaseCurrent Opinion in Neurobiology, 2011
- Similarities and differences in structure, expression, and functions of VLDLR and ApoER2Molecular Neurodegeneration, 2011
- Actions of β-Amyloid Protein on Human Neurons Are Expressed through the Amylin ReceptorThe American Journal of Pathology, 2011
- Decreased Clearance of CNS β-Amyloid in Alzheimer’s DiseaseScience, 2010
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Neuroprotective Actions of PIKE-L by Inhibition of SET Proteolytic Degradation by Asparagine EndopeptidaseMolecular Cell, 2008